ClinicalTrials.gg
CompletedNCT05473455Updated Mar 30, 2023

Value of Follicular Flushing. Randomised Controlled Trial

An interventional study of Experimental: Follicular aspiration with addition of follicular flushing. in Infertility, sponsored by Eugonia. Completed at 1 site in Greece. Open to female participants aged 18 Years to 43 Years. Per ClinicalTrials.gov, last updated 2023-03-30.

Sponsored by Eugonia · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
105
Allocation
Randomized
Ages
18 Years to 43 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 13 studies in Infertility by Eugonia — none open to participants now, none under way, none of them phase 3. Infertility · Eugonia.

Enrollment
5th of 10
105 · median 84
Started
2022
the only one that year
No phase
5 of 13
none open now
Registered
12th of 13
by date

Among the 13 studies in Infertility by Eugonia, this one is the 5th largest by enrollment of the 10 interventional ones that give a count, is the only one that started in 2022, is one of 5 with no phase, and was the 12th registered.

Infertility

2,090 studies on the registry are indexed under Infertility; 356 are open to participants now.

Browse Infertility studies →

Open to participants now

None of the 13 studies in Infertility by Eugonia is open now. The open studies under Infertility, anywhere →

Where they have run

Who these studies take

Of the 233 Infertility studies recruiting now, 43 (18%) set no upper age limit and 184 (79%) stop at 75 or younger; 27 take children under 18; 74 take healthy volunteers.

This study: 18 Years to 43 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 13 studies in Infertility by Eugonia as a file.
02

Study summary

The purpose of this study is to evaluate whether the addition of follicular flushing to the initial aspiration during oocyte retrieval increases the number of oocytes retrieved in women undergoing ovarian stimulation.

Read the detailed description

There is an ongoing debate regarding the effectiveness of follicular flushing during oocyte retrieval. Currently published studies and metanalyses suggest that follicular flushing does not improve live birth rate, clinical pregnancy rate or the number of oocytes retrieved. However, currently published studies may be confounded by the types of needle used, aspiration pressures, number of times flushing is repeated, etc. Additionally, follicular flushing should be examined in specific patient populations according to their response to ovarian stimulation.

In the current study, each woman will have one ovary (right or left) randomly assigned to be aspirated with or without the addition of follicular flushing. This study design ensures that clinical and demographic characteristics of the couple will not affect the outcomes evaluated. The primary endpoints will be the number of oocytes retrieved per ovary assigned to each group. Secondary outcomes will be the oocyte recovery rate (oocytes retrieved per follicle aspirated) oocyte maturation rate, fertilization rate, and embryo development per ovary assigned to each group.

The study population will include three subgroups according to observed ovarian response to ovarian stimulation (poor responders, normal responders, hyper responders). Assuming a minimum clinically significant difference in oocyte yield of 1 oocyte, a sample size of twenty patients per subgroup is required to yield 80% power.

Patients aged \<43 years with the presence of at least one follicles >11mm in each ovary on the day of triggering final oocyte maturation will be eligible for inclusion in the study. 60 patients (20 in each of the aforementioned subgroup) will be recruited and just prior to oocyte retrieval their left and right ovaries will be randomly allocated into flushing or the no-flushing group. In both ovaries all follicles greater than 11mm will be punctured by the same 16G double lumen needle, using the same aspiration pressure. In the flushing group, flushing will be performed up to a maximum of five times or until a cumulus oocyte complex (COC) is retrieved.

In the control group all follicles greater than 11mm will be aspirated by the same double lumen needle and no flushing will be performed.

All COCs will be grouped according to the ovary they originated from by the embryologists and their development will be recorded until Day 3 following fertilization (Number of MII oocytes, number of fertilized oocytes, number good quality Day 3 embryos).

03

Conditions studied

  • Infertility

Browse trials for

Keywords

  • Follicular Flushing
  • Oocyte Retrieval
04

Who can participate

Ages eligible
18 Years to 43 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Presence of both ovaries
  • 18-43 years old
  • At least one follicle >11mm present in each ovary on day of triggering final oocyte maturation.

Exclusion criteria

Exclusion Criteria:

  • Ovarian surgery
  • Monofolicular development
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
105 participants (actual)

Study arms

  • Experimental
    Follicular aspiration with addition of follicular flushing.

    All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle)

    Procedure: Experimental: Follicular aspiration with addition of follicular flushing.

  • No intervention
    Follicular aspiration only.

    All follicles will be aspirated and no flushing will be applied.

Interventions

  • ProcedureExperimental: Follicular aspiration with addition of follicular flushing.

    Follicular flushing if necessary up to 5 times using a double lumen needle for oocyte recovery

06

What researchers measure

Primary outcomes

  1. Number of oocytes retrieved

    Number of oocytes retrieved per ovary randomised

    Time frame: During oocyte collection (usually 10-30 minutes)

Secondary outcomes

  1. Oocyte recovery rate

    Number of oocytes retrieved per follicle aspirated

    Time frame: During oocyte collection (usually 10-30 minutes)

  2. Oocyte maturation rate

    Number of mature (metaphase-II) oocytes divided by the number of oocytes retrieved per ovary randomised

    Time frame: During oocyte denudation (usually 10-30 minutes)

  3. Fertilization rate

    Number of fertilised (2PN) oocytes divided by the number of matured oocytes retrieved per ovary randomised

    Time frame: During fertilisation check (usually 10 minutes)

  4. Percentage of good quality embryos on day 2/3

    Number of good quality embryos divided by the number of fertilized oocytes per ovary randomised

    Time frame: During embryo evaluation (usually 10 minutes)

07

Study locations

1 site
  • Eugonia Unit of Assisted Reproduction
    Athens, 11528, Greece
08

References and documents

Publications

  • von Horn K, Depenbusch M, Schultze-Mosgau A, Griesinger G. Randomized, open trial comparing a modified double-lumen needle follicular flushing system with a single-lumen aspiration needle in IVF patients with poor ovarian response. Hum Reprod. 2017 Apr 1;32(4):832-835. doi: 10.1093/humrep/dex019. PubMed 28333185 ↗
  • Franasiak JM. Follicular flushing: time to look elsewhere to improve in vitro fertilisation outcomes? BJOG. 2017 Jul;124(8):1197. doi: 10.1111/1471-0528.14628. No abstract available. PubMed 28276189 ↗
  • Roque M, Sampaio M, Geber S. Follicular flushing during oocyte retrieval: a systematic review and meta-analysis. J Assist Reprod Genet. 2012 Nov;29(11):1249-54. doi: 10.1007/s10815-012-9869-9. Epub 2012 Oct 13. PubMed 23065177 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2022 to primary completion in Dec 2022, 5 months.

Of 386 non-industry interventional studies with no phase under Infertility, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 5 months is below that.

Counting every sponsor, half of 416 studies reached it within 24 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2022
First posted
Jul 26, 2022
StartActual
Jul 15, 2022
Primary completionActual
Dec 30, 2022
CompletionActual
Dec 31, 2022
Last update
Mar 30, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 30, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05473455
Lead sponsor
Eugonia
Responsible party
Sponsor
First posted
Jul 26, 2022
Start date
Jul 15, 2022
Primary completion
Dec 30, 2022
Completion
Dec 31, 2022
Last update
Mar 30, 2023

Study contacts

Lainas, PhD
study director · Eugonia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion